Sign inGet started

Lucas Svetlana

Insider CIK 1781292 · LIFE Director · JSPR Director · SCTX Chief Business Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
JSPR Jasper Therapeutics, Inc. A Award deriv2026-07-312026-08-047,500— $07,500SEC↗
JSPR Jasper Therapeutics, Inc. A Award deriv2026-07-312026-08-047,500— $07,500SEC↗
SCTX Scribe Therapeutics, Inc. A Award deriv2026-07-232026-07-27109,426— $0109,426SEC↗
SCTX Scribe Therapeutics, Inc. A Award deriv2026-07-232026-07-27109,426— $0109,426SEC↗
SCTX Scribe Therapeutics, Inc. P Buy2026-07-232026-07-273,000$15.00 $45.0K3,000SEC↗
ATYR aTYR PHARMA INC A Award deriv2026-05-112026-05-1350,000— $050,000SEC↗
SCTX Scribe Therapeutics, Inc. A Award deriv2026-03-132026-07-279,547— $09,547SEC↗
JSPR Jasper Therapeutics, Inc. P Buy deriv2025-09-222025-09-2420,000— $020,000SEC↗
JSPR Jasper Therapeutics, Inc. P Buy2025-09-222025-09-2420,000$2.43 $48.6K20,000SEC↗
JSPR Jasper Therapeutics, Inc. A Award deriv2025-07-032025-07-037,500— $07,500SEC↗
ATYR aTYR PHARMA INC A Award deriv2025-05-012025-05-0250,000— $050,000SEC↗
JSPR Jasper Therapeutics, Inc. A Award deriv2024-06-182024-06-2015,000— $015,000SEC↗
LIFE aTYR PHARMA INC A Award deriv2024-05-222024-05-2324,000— $024,000SEC↗
LIFE aTYR PHARMA INC A Award deriv2023-05-172023-05-1912,000— $012,000SEC↗
LIFE aTYR PHARMA INC M Exercise deriv2023-04-262023-04-286,000— $00SEC↗
LIFE aTYR PHARMA INC M Exercise2023-04-262023-04-286,000— $06,000SEC↗
LIFE aTYR PHARMA INC A Award deriv2022-04-262022-04-286,000— $06,000SEC↗
LIFE aTYR PHARMA INC A Award deriv2021-04-282021-04-291,428— $01,428SEC↗
LIFE aTYR PHARMA INC A Award deriv2020-05-062020-05-081,428— $01,428SEC↗
LIFE aTYR PHARMA INC A Award deriv2019-06-282019-07-022,285— $02,285SEC↗